Syed Faisal Ahmed

Professor Syed Faisal Ahmed holds the Samson Gemmell Chair of Child Health at the University of Glasgow's College of Medicine. With over two decades of experience, he has established himself as a leading expert in pediatric endocrinology, particularly in rare endocrine conditions affecting children and adolescents. His work spans clinical practice, research, and international collaboration, with a focus on improving care standards for patients with Disorders of Sex Development (DSD) and Congenital Adrenal Hyperplasia (CAH). Professor Ahmed leads multiple international research initiatives and has built extensive networks across Europe and globally.

Professor Ahmed's research focuses on translational approaches to improve care for children with rare endocrine conditions. His primary interests include Disorders of Sex Development (DSD), Congenital Adrenal Hyperplasia (CAH), growth disorders, and bone health in endocrine conditions. He has pioneered international collaborative projects including EuroDSD (EUFP7, 2008-2011), I-DSD (MRC, 2011-2017), DSDnet (COST Action BM1303, 2013-2018), Endo-ERN (2016-present), EuRRECa (EU HaDEA, 2018-2022, EU4H 2024-2028), and EuRR-Bone (EU HaDEA, 2020-2023, EU4H 2024-2028). His work emphasizes developing standardized approaches for diagnosis, treatment, and outcome monitoring across international borders.

Analysis of Professor Ahmed's recent publications reveals a strong focus on clinical outcomes and quality of life in rare endocrine conditions, particularly Disorders of Sex Development and Congenital Adrenal Hyperplasia. His research spans from basic science investigations of molecular mechanisms to large-scale international registry studies. A notable trend is the increasing emphasis on patient-reported outcomes, transition from pediatric to adult care, and the development of standardized assessment tools for rare conditions. His work demonstrates how international collaboration can overcome the challenges of studying rare diseases through shared data and expertise.

• ESPE Research Award (2021)
• Editor in Chief of Endocrine Connections (2023)

Professor Ahmed has secured substantial funding from European Union programs (EUFP7, EU HaDEA), Medical Research Council (MRC), and COST Actions to support his international research networks. His GloBE-Reg project (launched in 2022), funded solely by industry, builds on lessons learned from earlier projects. He has supervised numerous researchers who have become co-authors on his publications, though specific student names are not listed in the provided material. His work has significantly influenced clinical guidelines, including the Society for Endocrinology UK guidance on the initial evaluation of suspected Disorders of Sex Development.

Professor Ahmed leads collaborative networks rather than a single physical laboratory. His primary research infrastructure consists of international registries including EuRRECa (European Registries for Rare Endocrine Conditions), I-DSD, and I-CAH. These platforms facilitate data collection across multiple countries and institutions, enabling research on rare conditions that would be impossible within single centers. His work with Endo-ERN (European Reference Network on Rare Endocrine Conditions) connects specialists across Europe to share expertise and establish best practices for rare endocrine disorders.